SPRB - Spruce Biosciences - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-24.23M

Cash

120.5M

Avg Qtr Burn

-7.528M

Short % of Float

0.66%

Insider Ownership

0.44%

Institutional Own.

91.76%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Tildacerfont Details Congenital adrenal hyperplasia, Primary biliary cholangitis, Liver disease Big Mover™ Suspected Mover™ Susp. Mover™	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tildacerfont Details Congenital adrenal hyperplasia Big Mover™ Suspected Mover™ Susp. Mover™	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tildacerfont Details Polycystic ovary syndrome	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.